The article offers suggestion to pharmacists for finding out answers to their questions about drugs and insurance coverage for their patients with multiple sclerosis (MS). The National MS Society provides...
The AJMC® Multiple Sclerosis compendium is a comprehensive resource for clinical news and expert insights for the disabling disease that impacts the brain and spinal cord.
Multiple sclerosis (MS) is defined as a chronic, often progressive and disabling disease that attacks the body’s central nervous system. People affected by this condition may experience a variety of symptoms based on the disease progression and their own unique characteristics. The etiology is unkn...
As multiple sclerosis is a medical condition that is progressive, how you will be rated will depend on whether your condition is stable, or whether the condition is more aggressive and the length of time you have had the condition. Life insurance companies view MS as a higher risk to ...
BeCare Link has developed software that enables the traditional in-person multiple sclerosis assessment to be done remotely on a patient’s own mobile device. The startup was named the winner of MedCity’s recent Pitch Perfect contest.
Patients covered by federal or state healthcare programs, including Medicare and Medicaid, are not eligible for assistance. This program is open to residents of the U.S. and U.S. territories with relapsing forms of multiple sclerosis who are starting or presently taking EMD Serono RMS product(...
Regional variations of multiple sclerosis prevalence in French farmers We estimated the regional and national prevalence of multiple sclerosis in France on 1 January 2003, based on the computerised database of the national farmer health insurance system ("Mutualit茅 Sociale Agricole"). There were 2667...
Barry Hendin, MD: Multiple sclerosis [MS] is defined as an autoimmune disorder in which the immune system—which should be targeting bacteria, viruses, and pathogens—is instead mis-programmed to attack the myelin of the central nervous system. Unfortunately, the nerve is also an innocent...
Multiple Sclerosis by Spherix Global Insights. But insurance is having an increasing impact on treatment decisions, the report also found, according to a Spherix press release. More patients are receiving less than optimal care because of inadequate or inferior insurance coverage, and neurologists repo...
Learn about OCREVUS® (ocrelizumab), a prescription medicine used for multiple sclerosis (MS) treatment in adults with relapsing or primary progressive multiple sclerosis, available in 3 different administration options: a 4-hour infusion, a 2-hour inf